Business
Business
12
Feb
2024
€2.7 million to begin Phase IIa trials for CTH120 in Fragile X syndrome
The Spanish Ministry of Science and Innovation back joint project by Connecta Therapeutics, the CRG, IMIM and I3PT
08
Feb
2024
CRG and Almirall partner to identify new biomarkers for atopic dermatitis treatments
The Proteomics Unit will work with Almirall to create advanced disease models
18
Jan
2024
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
The agreement is the first of its kind in Spain
30
Nov
2023
ALLO X, a CRG spinoff, created to tackle 'undruggable' proteins
ALLO X is the seventh company created by researchers at the CRG, launched with the support of Asabys
18
Jul
2023
CRG spin-off Orikine Bio closes 5.5 million euro seed financing round
The company, financed by Asabys Partners and AdBio, is the latest start-up launched by researchers at the CRG
25
May
2023
CRG teams up with Almirall to develop new preclinical models for non-melanoma skin cancer
Di Croce lab's group will leverage their expertise to help study the most frequent type of cancer
16
Mar
2023
‘Space bacteria’ set to land in Barcelona
yuri and CRG sign first worldwide agreement between a commercial space biotech company and a biomedical research institute
25
Oct
2022
CRG spin-off Seqera Labs raises 22 million euros in Series A funding
The success of the start-up highlights the CRG's commitment to technology transfer and investment in the economy
16
Feb
2022
CRG and PerkinElmer’s SIRION Biotech to Develop New Generation AAV Vectors for Type-1 and Type-2 Diabetes Gene Therapy
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
26
Oct
2021
Chemotargets and the CRG ally to accelerate the development of new treatments
Partnership aims to make new drugs that respond to unmet clinical needs
Pages
The Spanish Ministry of Science and Innovation back joint project by Connecta Therapeutics, the CRG, IMIM and I3PT
The Proteomics Unit will work with Almirall to create advanced disease models
The agreement is the first of its kind in Spain
ALLO X is the seventh company created by researchers at the CRG, launched with the support of Asabys
The company, financed by Asabys Partners and AdBio, is the latest start-up launched by researchers at the CRG
Di Croce lab's group will leverage their expertise to help study the most frequent type of cancer
yuri and CRG sign first worldwide agreement between a commercial space biotech company and a biomedical research institute
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Partnership aims to make new drugs that respond to unmet clinical needs